• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00516900
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Nausea (1970); Vomiting (2144)
Event Date 03/28/2019
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to report the suspect device lot number; therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2019 that a wallflex esophageal partially covered stent had been implanted to treat a malignant stricture in the distal esophagus during a stent placement procedure performed on (b)(6) 2018.After stent placement, the patient's cancer was treated with chemotherapy and radiation.According to the complainant, on (b)(6) 2019, the patient presented with pain, nausea and regurgitation.An esophagogastroduodenoscopy (egd) procedure was performed to examine the stent, and during the procedure, it was observed that the stent was patent and appeared to be in good position.The stent remains implanted and the physician didn't note any issues with the stent.Per the physician, the patient's pain was not related to the stent and the patient didn't have any change in pain related to the stent.In the physician's opinion, the nausea and vomiting were probably due to uncontrolled reflux post stent placement.The patient was treated with zofran, reglan and a high dose of ppi (proton pump inhibitor) to relieve nausea and vomiting as prescribed by the physician.Reportedly, the patient's current condition was reported to be fine but the nausea and vomiting has not yet resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key8550890
MDR Text Key143098774
Report Number3005099803-2019-02212
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729765240
UDI-Public08714729765240
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K073266
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00516900
Device Catalogue Number1690
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/29/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age54 YR
-
-